CClinicalTrials.gg
TerminatedNCT01770340Updated Feb 21, 2021

Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial

A Phase 4 interventional study of Radical prostatectomy with implantation of allograft and Radical prostatectomy without implantation of allograft in Erectile Dysfunction Following Radical Prostatectomy, sponsored by Kantonsspital Winterthur KSW. Terminated at 1 site in Switzerland. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-21.

Sponsored by Kantonsspital Winterthur KSW · Phase 4, Interventional, and Treatment

Why this study was terminated
Poor recruitment, Interim analysis: The rates of pts who reached primary and secondary endpoints were lower than expected.
Phase
Phase 4
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

Earlier studies were able to show that an improvement of the erectile function following a non-nerve sparing radical prostatectomy could be achieved using an autologous nerve graft.

The investigators evaluate the use of the implantation of the allogenic nerve graft Avance® in patients undergoing non nerve-sparing radical prostatectomy.

Read the detailed description

In this prospective randomised and single-blind, clinical phase-IV study, 60 patients are randomized into the treatment group and the control group. The follow-up is at least 24 months.

The inclusion criteria were localized prostate cancers cT3 and/or Gleason score ≥ 7 (a or b) and/or prostate-specific antigen (PSA) ≥ 20 ng/ml and furthermore an erectile function with an IIEF ≥ 21 (IIEF-6).

The operation carried out is a standardised, robot assisted laparoscopic radical prostatectomy with total excision of both neurovascular bundles.

The Outcome measurement is done with the "quality of life questionnaire before and after prostate surgery" that includes the "International Index of Erectile Function" (IIEF) questionnaire.

The limitations are a small cohort, a short observation period and the lack of statistical analysis due to a still low number of patients.

02

Conditions studied

  • Erectile Dysfunction Following Radical Prostatectomy

Browse trials for

Keywords

  • radical prostatectomy
  • erectile function
  • nerve grafting
  • allogenic
  • prostate cancer
  • Allogenic nerve graft
  • Time required for nerve grafting
03

In context

Erectile Dysfunction

683 studies on the registry are indexed under Erectile Dysfunction; 117 are open to participants now.

This study's enrollment of 30 is below the median of 72 across 542 interventional studies indexed under Erectile Dysfunction.

Browse Erectile Dysfunction studies →

Lead sponsor

Kantonsspital Winterthur KSW is the lead sponsor of 34 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Localized intermediate-risk or high-risk prostate cancer cT3
  • Gleason score ≥ 7 (3+4 and/or 4+3) and/or
  • PSA ≥ 20 ng/ml
  • intact preoperative erectile function with an IIEF ≥ 21 (IIEF-6).

Exclusion criteria

Exclusion Criteria:

  • IIEF \< 21
  • Operations in the past 6 months which could limit the erectile function
  • Erectile dysfunction in the history or current medication for erectile dysfunction
  • Current involvement in another comparable study.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Sham comparator
    Control group

    Radical prostatectomy without implantation of allograft

    Procedure: Radical prostatectomy without implantation of allograft

  • Experimental
    Treatment group

    Radical prostatectomy with implantation of allograft

    Biological: Radical prostatectomy with implantation of allograft

Interventions

  • BiologicalRadical prostatectomy with implantation of allograft

    Interposition of resected neurovascular bundles with allograft Avance®

  • ProcedureRadical prostatectomy without implantation of allograft

    No interposition of resected neurvascular bundles

06

What researchers measure

Primary outcomes

  1. Erectile function score (IIEF: international index of erectile function) after non nerve sparing radical prostatectomy

    Erectile function score (IIEF: international index of erectile function) after non nerve sparing radical prostatectomy. To show a complete impotence in the control group and an enhancement of the initial postoperative impotence in the treatment group

    Time frame: 24 months

Secondary outcomes

  1. Number of Participants with Adverse Events as a Measure of Safety and Tolerability

    Monitoring of side effects and complications in connection with the nerve-implantation.

    Time frame: 24 months

Other outcomes

  1. Documented will be the extra time required for the nerve implantation

    How much operation-time takes the nerve implantation? The time is stopped which is required for the implantation of the nerve. Start is when the prostate was removed and was deposited in the extraction bag. Stop when the anastomosis of the nerves is stitched and the anastomosis of the urethra begins.

    Time frame: at the time of operation

07

Study locations

1 site
  • Kantonsspital Winterthur
    Winterthur, Kanton Zürich 8401, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01770340
Lead sponsor
Kantonsspital Winterthur KSW
Responsible party
Sponsor
First posted
Jan 17, 2013
Start date
Jan 2011
Primary completion
Apr 2017
Completion
Jul 1, 2020
Last update
Feb 21, 2021

Study contacts

Hubert John, Chefarzt
principal investigator · Kantonsspital Winterthur KSW

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion